Yet Another Heart Stem Cell Trial

A great deal of work is presently taking place on first generation regenerative therapies for heart damage. Here is another example: "The first-of-its-kind study in heart attack patients will seek to demonstrate the safety, and roughly measure efficacy, of three intravenous doses of adult human stem cells versus placebo in lessening damage to heart muscle within ten days of first heart attack. The treatment recently passed an early safety test and has been approved for study in more patients at higher doses. That process will get underway shortly ... The potential to re-build damaged heart muscle by implanting stem cells that then become new muscle cells is one of the most exciting in cardiology."

Link: http://www.urmc.rochester.edu/pr/news/story.cfm?id=1001